CA2390053A1 - Augmentation and repair of age-related soft tissue defects - Google Patents

Info

Publication number

CA2390053A1

CA2390053A1 CA002390053A CA2390053A CA2390053A1 CA 2390053 A1 CA2390053 A1 CA 2390053A1 CA 002390053 A CA002390053 A CA 002390053A CA 2390053 A CA2390053 A CA 2390053A CA 2390053 A1 CA2390053 A1 CA 2390053A1

Authority

CA

Canada

Prior art keywords

tissue

fibroblasts

cells

culture

composition

Prior art date

1999-11-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 230000008439 repair process Effects 0.000 title claims abstract description 62
• 230000007547 defect Effects 0.000 title claims abstract description 61
• 230000003416 augmentation Effects 0.000 title claims abstract description 50
• 210000004872 soft tissue Anatomy 0.000 title description 20
• 210000001519 tissue Anatomy 0.000 claims abstract description 160
• 210000004027 cell Anatomy 0.000 claims abstract description 152
• 238000000034 method Methods 0.000 claims abstract description 140
• 238000002347 injection Methods 0.000 claims abstract description 92
• 239000007924 injection Substances 0.000 claims abstract description 92
• 208000027418 Wounds and injury Diseases 0.000 claims abstract description 88
• 210000003491 skin Anatomy 0.000 claims abstract description 86
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 70
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 70
• 210000002744 extracellular matrix Anatomy 0.000 claims abstract description 70
• 201000004384 Alopecia Diseases 0.000 claims abstract description 59
• 210000003041 ligament Anatomy 0.000 claims abstract description 55
• 210000004207 dermis Anatomy 0.000 claims abstract description 47
• 206010019909 Hernia Diseases 0.000 claims abstract description 39
• 210000000481 breast Anatomy 0.000 claims abstract description 36
• 210000002435 tendon Anatomy 0.000 claims abstract description 36
• 241000282414 Homo sapiens Species 0.000 claims abstract description 35
• 230000003676 hair loss Effects 0.000 claims abstract description 33
• 210000003195 fascia Anatomy 0.000 claims abstract description 30
• 210000004400 mucous membrane Anatomy 0.000 claims abstract description 28
• 210000005070 sphincter Anatomy 0.000 claims abstract description 27
• 208000035484 Cellulite Diseases 0.000 claims abstract description 23
• 206010049752 Peau d'orange Diseases 0.000 claims abstract description 23
• 230000036232 cellulite Effects 0.000 claims abstract description 23
• 231100000241 scar Toxicity 0.000 claims abstract description 23
• 208000032544 Cicatrix Diseases 0.000 claims abstract description 11
• 230000037387 scars Effects 0.000 claims abstract description 11
• 206010065433 Ligament rupture Diseases 0.000 claims abstract description 5
• 210000003754 fetus Anatomy 0.000 claims abstract description 4
• 210000002950 fibroblast Anatomy 0.000 claims description 147
• 230000002500 effect on skin Effects 0.000 claims description 69
• 239000000203 mixture Substances 0.000 claims description 55
• 238000000338 in vitro Methods 0.000 claims description 44
• 210000001789 adipocyte Anatomy 0.000 claims description 40
• 210000000229 preadipocyte Anatomy 0.000 claims description 23
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
• 208000021302 gastroesophageal reflux disease Diseases 0.000 claims description 17
• 210000004962 mammalian cell Anatomy 0.000 claims description 17
• 230000003190 augmentative effect Effects 0.000 claims description 13
• 206010047370 Vesicoureteric reflux Diseases 0.000 claims description 10
• 201000008618 vesicoureteral reflux Diseases 0.000 claims description 10
• 208000031355 vesicoureteral reflux 1 Diseases 0.000 claims description 10
• 206010021639 Incontinence Diseases 0.000 claims description 9
• 201000010099 disease Diseases 0.000 claims description 9
• 230000000366 juvenile effect Effects 0.000 claims description 9
• 230000007812 deficiency Effects 0.000 claims description 8
• 208000035475 disorder Diseases 0.000 claims description 8
• 230000001969 hypertrophic effect Effects 0.000 claims description 8
• 230000007257 malfunction Effects 0.000 claims description 8
• 210000000651 myofibroblast Anatomy 0.000 claims description 8
• 238000011065 in-situ storage Methods 0.000 claims description 3
• 206010052428 Wound Diseases 0.000 abstract description 82
• 210000003205 muscle Anatomy 0.000 abstract description 50
• 210000002808 connective tissue Anatomy 0.000 abstract description 38
• 210000003780 hair follicle Anatomy 0.000 abstract description 32
• 210000000577 adipose tissue Anatomy 0.000 abstract description 22
• 239000011159 matrix material Substances 0.000 abstract description 19
• 239000000725 suspension Substances 0.000 abstract description 15
• 238000002513 implantation Methods 0.000 abstract description 12
• 230000007774 longterm Effects 0.000 abstract description 12
• 239000000470 constituent Substances 0.000 abstract description 10
• 210000004748 cultured cell Anatomy 0.000 abstract description 10
• 208000028169 periodontal disease Diseases 0.000 abstract description 8
• 239000010410 layer Substances 0.000 description 79
• 108010035532 Collagen Proteins 0.000 description 68
• 102000008186 Collagen Human genes 0.000 description 68
• 229920001436 collagen Polymers 0.000 description 66
• 210000004209 hair Anatomy 0.000 description 64
• 238000001356 surgical procedure Methods 0.000 description 46
• 239000000463 material Substances 0.000 description 40
• 239000003925 fat Substances 0.000 description 33
• 239000007943 implant Substances 0.000 description 30
• 238000011282 treatment Methods 0.000 description 28
• 210000004761 scalp Anatomy 0.000 description 25
• 241000283690 Bos taurus Species 0.000 description 24
• 238000007920 subcutaneous administration Methods 0.000 description 24
• 210000002966 serum Anatomy 0.000 description 22
• 238000002360 preparation method Methods 0.000 description 21
• 108010045569 atelocollagen Proteins 0.000 description 20
• 210000000988 bone and bone Anatomy 0.000 description 20
• 230000003387 muscular Effects 0.000 description 20
• 229920001296 polysiloxane Polymers 0.000 description 20
• 230000008569 process Effects 0.000 description 20
• 210000000626 ureter Anatomy 0.000 description 20
• 231100000360 alopecia Toxicity 0.000 description 19
• 239000000835 fiber Substances 0.000 description 19
• 230000003698 anagen phase Effects 0.000 description 18
• 230000001684 chronic effect Effects 0.000 description 18
• 239000000126 substance Substances 0.000 description 16
• 210000003708 urethra Anatomy 0.000 description 16
• 230000035876 healing Effects 0.000 description 14
• 230000015572 biosynthetic process Effects 0.000 description 13
• 230000003778 catagen phase Effects 0.000 description 13
• 210000002615 epidermis Anatomy 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 13
• 102000004127 Cytokines Human genes 0.000 description 12
• 108090000695 Cytokines Proteins 0.000 description 12
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 12
• 238000013459 approach Methods 0.000 description 12
• 230000004054 inflammatory process Effects 0.000 description 12
• 208000014674 injury Diseases 0.000 description 12
• 230000001154 acute effect Effects 0.000 description 11
• 210000003484 anatomy Anatomy 0.000 description 11
• 239000003098 androgen Substances 0.000 description 11
• 230000003325 follicular Effects 0.000 description 11
• 239000001963 growth medium Substances 0.000 description 11
• 208000024963 hair loss Diseases 0.000 description 11
• 230000001965 increasing effect Effects 0.000 description 11
• 230000036961 partial effect Effects 0.000 description 11
• 230000003239 periodontal effect Effects 0.000 description 11
• 239000000758 substrate Substances 0.000 description 11
• 230000003797 telogen phase Effects 0.000 description 11
• 230000029663 wound healing Effects 0.000 description 11
• 206010061218 Inflammation Diseases 0.000 description 10
• 238000001574 biopsy Methods 0.000 description 10
• 150000001875 compounds Chemical class 0.000 description 10
• 229940079593 drug Drugs 0.000 description 10
• 239000003814 drug Substances 0.000 description 10
• 210000000981 epithelium Anatomy 0.000 description 10
• 238000005755 formation reaction Methods 0.000 description 10
• 230000007246 mechanism Effects 0.000 description 10
• -1 polytetrafluoro-ethylene Polymers 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• 239000007787 solid Substances 0.000 description 10
• 206010028980 Neoplasm Diseases 0.000 description 9
• 208000004210 Pressure Ulcer Diseases 0.000 description 9
• 230000002159 abnormal effect Effects 0.000 description 9
• 229940030486 androgens Drugs 0.000 description 9
• 230000008602 contraction Effects 0.000 description 9
• 230000006378 damage Effects 0.000 description 9
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
• 230000000694 effects Effects 0.000 description 9
• 210000003238 esophagus Anatomy 0.000 description 9
• 239000000499 gel Substances 0.000 description 9
• 239000002953 phosphate buffered saline Substances 0.000 description 9
• 239000000243 solution Substances 0.000 description 9
• 241000287107 Passer Species 0.000 description 8
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
• 230000003187 abdominal effect Effects 0.000 description 8
• 230000009471 action Effects 0.000 description 8
• 230000015556 catabolic process Effects 0.000 description 8
• 239000000512 collagen gel Substances 0.000 description 8
• 238000002316 cosmetic surgery Methods 0.000 description 8
• 230000001605 fetal effect Effects 0.000 description 8
• 239000012530 fluid Substances 0.000 description 8
• 210000002510 keratinocyte Anatomy 0.000 description 8
• 229920003023 plastic Polymers 0.000 description 8
• 239000004033 plastic Substances 0.000 description 8
• 108090000623 proteins and genes Proteins 0.000 description 8
• 108091005804 Peptidases Proteins 0.000 description 7
• 102000035195 Peptidases Human genes 0.000 description 7
• 206010066218 Stress Urinary Incontinence Diseases 0.000 description 7
• 201000011510 cancer Diseases 0.000 description 7
• 210000000845 cartilage Anatomy 0.000 description 7
• 230000003111 delayed effect Effects 0.000 description 7
• 230000002255 enzymatic effect Effects 0.000 description 7
• 230000012010 growth Effects 0.000 description 7
• 230000003779 hair growth Effects 0.000 description 7
• 238000013508 migration Methods 0.000 description 7
• 239000002245 particle Substances 0.000 description 7
• 102000004169 proteins and genes Human genes 0.000 description 7
• 230000011514 reflex Effects 0.000 description 7
• 238000010992 reflux Methods 0.000 description 7
• 230000008733 trauma Effects 0.000 description 7
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 239000003795 chemical substances by application Substances 0.000 description 6
• 230000001419 dependent effect Effects 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 210000000494 inguinal canal Anatomy 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• 238000002690 local anesthesia Methods 0.000 description 6
• 230000005012 migration Effects 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 230000037390 scarring Effects 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 210000004304 subcutaneous tissue Anatomy 0.000 description 6
• 229960003604 testosterone Drugs 0.000 description 6
• 210000002700 urine Anatomy 0.000 description 6
• 206010002091 Anaesthesia Diseases 0.000 description 5
• 108010014258 Elastin Proteins 0.000 description 5
• 102000016942 Elastin Human genes 0.000 description 5
• 108010073385 Fibrin Proteins 0.000 description 5
• 102000009123 Fibrin Human genes 0.000 description 5
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
• 208000035901 Ischaemic ulcer Diseases 0.000 description 5
• 206010028851 Necrosis Diseases 0.000 description 5
• 239000004365 Protease Substances 0.000 description 5
• 206010046543 Urinary incontinence Diseases 0.000 description 5
• 210000003815 abdominal wall Anatomy 0.000 description 5
• 210000001909 alveolar process Anatomy 0.000 description 5
• 230000037005 anaesthesia Effects 0.000 description 5
• 206010068168 androgenetic alopecia Diseases 0.000 description 5
• 210000001264 anterior cruciate ligament Anatomy 0.000 description 5
• 230000004663 cell proliferation Effects 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 210000001612 chondrocyte Anatomy 0.000 description 5
• 239000000501 collagen implant Substances 0.000 description 5
• 239000002537 cosmetic Substances 0.000 description 5
• 238000004132 cross linking Methods 0.000 description 5
• 238000005520 cutting process Methods 0.000 description 5
• 229920002549 elastin Polymers 0.000 description 5
• 229950003499 fibrin Drugs 0.000 description 5
• 239000000945 filler Substances 0.000 description 5
• 230000002496 gastric effect Effects 0.000 description 5
• 210000004195 gingiva Anatomy 0.000 description 5
• 239000003102 growth factor Substances 0.000 description 5
• 229940088597 hormone Drugs 0.000 description 5
• 239000005556 hormone Substances 0.000 description 5
• 238000011534 incubation Methods 0.000 description 5
• 230000033001 locomotion Effects 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 210000004379 membrane Anatomy 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 230000017074 necrotic cell death Effects 0.000 description 5
• 230000000750 progressive effect Effects 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 238000007634 remodeling Methods 0.000 description 5
• 230000002269 spontaneous effect Effects 0.000 description 5
• 210000002784 stomach Anatomy 0.000 description 5
• 210000000689 upper leg Anatomy 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
• 201000006082 Chickenpox Diseases 0.000 description 4
• 206010010356 Congenital anomaly Diseases 0.000 description 4
• 206010056340 Diabetic ulcer Diseases 0.000 description 4
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
• 108010067306 Fibronectins Proteins 0.000 description 4
• 102000016359 Fibronectins Human genes 0.000 description 4
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 4
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 4
• 239000004809 Teflon Substances 0.000 description 4
• 229920006362 Teflon® Polymers 0.000 description 4
• 206010046980 Varicella Diseases 0.000 description 4
• 208000000558 Varicose Ulcer Diseases 0.000 description 4
• 239000012620 biological material Substances 0.000 description 4
• 210000004369 blood Anatomy 0.000 description 4
• 239000008280 blood Substances 0.000 description 4
• 230000036770 blood supply Effects 0.000 description 4
• 210000004204 blood vessel Anatomy 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 238000004140 cleaning Methods 0.000 description 4
• 238000012937 correction Methods 0.000 description 4
• 239000006071 cream Substances 0.000 description 4
• 238000001804 debridement Methods 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 230000008021 deposition Effects 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 230000001815 facial effect Effects 0.000 description 4
• 210000004013 groin Anatomy 0.000 description 4
• 230000003054 hormonal effect Effects 0.000 description 4
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
• 230000009851 immunogenic response Effects 0.000 description 4
• 230000006698 induction Effects 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 210000000111 lower esophageal sphincter Anatomy 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 230000009245 menopause Effects 0.000 description 4
• 230000011278 mitosis Effects 0.000 description 4
• 210000004877 mucosa Anatomy 0.000 description 4
• 230000001338 necrotic effect Effects 0.000 description 4
• 210000002445 nipple Anatomy 0.000 description 4
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 210000003689 pubic bone Anatomy 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 238000003860 storage Methods 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 238000012360 testing method Methods 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• 230000003202 urodynamic effect Effects 0.000 description 4
• NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 206010003497 Asphyxia Diseases 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• 206010016228 Fasciitis Diseases 0.000 description 3
• 108010072959 Fibrel Proteins 0.000 description 3
• 208000032843 Hemorrhage Diseases 0.000 description 3
• 208000029836 Inguinal Hernia Diseases 0.000 description 3
• 102000007547 Laminin Human genes 0.000 description 3
• 108010085895 Laminin Proteins 0.000 description 3
• 239000004677 Nylon Substances 0.000 description 3
• 239000004743 Polypropylene Substances 0.000 description 3
• 108010081750 Reticulin Proteins 0.000 description 3
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
• 208000000921 Urge Urinary Incontinence Diseases 0.000 description 3
• 230000009102 absorption Effects 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 230000006978 adaptation Effects 0.000 description 3
• 230000002411 adverse Effects 0.000 description 3
• 229940072056 alginate Drugs 0.000 description 3
• 235000010443 alginic acid Nutrition 0.000 description 3
• 229920000615 alginic acid Polymers 0.000 description 3
• 230000012292 cell migration Effects 0.000 description 3
• 239000001913 cellulose Substances 0.000 description 3
• 229920002678 cellulose Polymers 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 208000037976 chronic inflammation Diseases 0.000 description 3
• 210000001608 connective tissue cell Anatomy 0.000 description 3
• 229920001577 copolymer Polymers 0.000 description 3
• 125000004122 cyclic group Chemical group 0.000 description 3
• 230000003412 degenerative effect Effects 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 235000014113 dietary fatty acids Nutrition 0.000 description 3
• 210000005069 ears Anatomy 0.000 description 3
• 210000004177 elastic tissue Anatomy 0.000 description 3
• 229940088598 enzyme Drugs 0.000 description 3
• 239000000194 fatty acid Substances 0.000 description 3
• 229930195729 fatty acid Natural products 0.000 description 3
• 150000004665 fatty acids Chemical class 0.000 description 3
• 239000006260 foam Substances 0.000 description 3
• 210000003953 foreskin Anatomy 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 230000000762 glandular Effects 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 230000003179 granulation Effects 0.000 description 3
• 238000005469 granulation Methods 0.000 description 3
• 230000009583 hair follicle growth Effects 0.000 description 3
• 239000000017 hydrogel Substances 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 238000012606 in vitro cell culture Methods 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 230000003780 keratinization Effects 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 210000003127 knee Anatomy 0.000 description 3
• 230000004130 lipolysis Effects 0.000 description 3
• 238000007726 management method Methods 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 210000002752 melanocyte Anatomy 0.000 description 3
• 235000013336 milk Nutrition 0.000 description 3
• 239000008267 milk Substances 0.000 description 3
• 210000004080 milk Anatomy 0.000 description 3
• 230000000394 mitotic effect Effects 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 229920001778 nylon Polymers 0.000 description 3
• 210000002640 perineum Anatomy 0.000 description 3
• 229920000728 polyester Polymers 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 229920001155 polypropylene Polymers 0.000 description 3
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
• 239000011148 porous material Substances 0.000 description 3
• 230000002028 premature Effects 0.000 description 3
• 238000004321 preservation Methods 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 230000005855 radiation Effects 0.000 description 3
• 238000002278 reconstructive surgery Methods 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000003252 repetitive effect Effects 0.000 description 3
• 238000007790 scraping Methods 0.000 description 3
• 210000004706 scrotum Anatomy 0.000 description 3
• 239000002356 single layer Substances 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 238000011477 surgical intervention Methods 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 230000009885 systemic effect Effects 0.000 description 3
• 230000009772 tissue formation Effects 0.000 description 3
• 230000000699 topical effect Effects 0.000 description 3
• 231100000397 ulcer Toxicity 0.000 description 3
• 210000001835 viscera Anatomy 0.000 description 3
• 230000010388 wound contraction Effects 0.000 description 3
• 206010060954 Abdominal Hernia Diseases 0.000 description 2
• 208000021970 Abdominal wall defect Diseases 0.000 description 2
• 206010001767 Alopecia universalis Diseases 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 206010009269 Cleft palate Diseases 0.000 description 2
• 102000001187 Collagen Type III Human genes 0.000 description 2
• 108010069502 Collagen Type III Proteins 0.000 description 2
• 102000029816 Collagenase Human genes 0.000 description 2
• 108060005980 Collagenase Proteins 0.000 description 2
• 208000032170 Congenital Abnormalities Diseases 0.000 description 2
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
• 208000006558 Dental Calculus Diseases 0.000 description 2
• 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
• 108010049003 Fibrinogen Proteins 0.000 description 2
• 102000008946 Fibrinogen Human genes 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
• 229930182566 Gentamicin Natural products 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 206010061223 Ligament injury Diseases 0.000 description 2
• XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
• ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
• 208000003445 Mouth Neoplasms Diseases 0.000 description 2
• 206010030216 Oesophagitis Diseases 0.000 description 2
• 208000031481 Pathologic Constriction Diseases 0.000 description 2
• 208000006735 Periostitis Diseases 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 206010067171 Regurgitation Diseases 0.000 description 2
• 241000283984 Rodentia Species 0.000 description 2
• 206010040867 Skin hypertrophy Diseases 0.000 description 2
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
• 208000002847 Surgical Wound Diseases 0.000 description 2
• 244000269722 Thea sinensis Species 0.000 description 2
• 208000007536 Thrombosis Diseases 0.000 description 2
• 206010044310 Tracheo-oesophageal fistula Diseases 0.000 description 2
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
• 206010052779 Transplant rejections Diseases 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 208000025865 Ulcer Diseases 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 210000001015 abdomen Anatomy 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• 230000001464 adherent effect Effects 0.000 description 2
• 208000004631 alopecia areata Diseases 0.000 description 2
• 208000032775 alopecia universalis congenita Diseases 0.000 description 2
• 230000003444 anaesthetic effect Effects 0.000 description 2
• 230000033115 angiogenesis Effects 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 239000005557 antagonist Substances 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 210000004883 areola Anatomy 0.000 description 2
• 239000012298 atmosphere Substances 0.000 description 2
• 230000004900 autophagic degradation Effects 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 229960000074 biopharmaceutical Drugs 0.000 description 2
• 230000001851 biosynthetic effect Effects 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 230000001680 brushing effect Effects 0.000 description 2
• 210000001217 buttock Anatomy 0.000 description 2
• RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
• 230000002308 calcification Effects 0.000 description 2
• 239000000648 calcium alginate Substances 0.000 description 2
• 235000010410 calcium alginate Nutrition 0.000 description 2
• 229960002681 calcium alginate Drugs 0.000 description 2
• OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 235000013351 cheese Nutrition 0.000 description 2
• YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 2
• 230000006020 chronic inflammation Effects 0.000 description 2
• 206010009259 cleft lip Diseases 0.000 description 2
• 229960001338 colchicine Drugs 0.000 description 2
• 229940096422 collagen type i Drugs 0.000 description 2
• 229960002424 collagenase Drugs 0.000 description 2
• 230000001010 compromised effect Effects 0.000 description 2
• 229960004397 cyclophosphamide Drugs 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 239000003398 denaturant Substances 0.000 description 2
• 210000004268 dentin Anatomy 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 235000005911 diet Nutrition 0.000 description 2
• 235000013367 dietary fats Nutrition 0.000 description 2
• 210000001339 epidermal cell Anatomy 0.000 description 2
• 208000006881 esophagitis Diseases 0.000 description 2
• 239000000262 estrogen Substances 0.000 description 2
• 210000000416 exudates and transudate Anatomy 0.000 description 2
• 210000000109 fascia lata Anatomy 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 108060002894 fibrillar collagen Proteins 0.000 description 2
• 102000013373 fibrillar collagen Human genes 0.000 description 2
• 229940012952 fibrinogen Drugs 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 238000002695 general anesthesia Methods 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 210000004907 gland Anatomy 0.000 description 2
• 108010020199 glutaraldehyde-cross-linked collagen Proteins 0.000 description 2
• 210000000442 hair follicle cell Anatomy 0.000 description 2
• 210000004919 hair shaft Anatomy 0.000 description 2
• 210000001624 hip Anatomy 0.000 description 2
• 239000000416 hydrocolloid Substances 0.000 description 2
• 230000001096 hypoplastic effect Effects 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 230000028709 inflammatory response Effects 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 210000000545 internal inguinal ring Anatomy 0.000 description 2
• 230000016507 interphase Effects 0.000 description 2
• 208000003243 intestinal obstruction Diseases 0.000 description 2
• 210000000936 intestine Anatomy 0.000 description 2
• 230000002427 irreversible effect Effects 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 230000005923 long-lasting effect Effects 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 238000009607 mammography Methods 0.000 description 2
• 201000006527 mandibular cancer Diseases 0.000 description 2
• 230000018984 mastication Effects 0.000 description 2
• 238000010077 mastication Methods 0.000 description 2
• 201000009023 maxillary cancer Diseases 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• 238000001531 micro-dissection Methods 0.000 description 2
• 239000012982 microporous membrane Substances 0.000 description 2
• 239000004005 microsphere Substances 0.000 description 2
• 229960003632 minoxidil Drugs 0.000 description 2
• 210000003098 myoblast Anatomy 0.000 description 2
• 210000001087 myotubule Anatomy 0.000 description 2
• 210000005036 nerve Anatomy 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 235000016709 nutrition Nutrition 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 238000012829 orthopaedic surgery Methods 0.000 description 2
• 210000001672 ovary Anatomy 0.000 description 2
• 208000024449 overflow incontinence Diseases 0.000 description 2
• 210000003254 palate Anatomy 0.000 description 2
• 206010033675 panniculitis Diseases 0.000 description 2
• 239000012188 paraffin wax Substances 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 230000007310 pathophysiology Effects 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 210000003903 pelvic floor Anatomy 0.000 description 2
• 210000003899 penis Anatomy 0.000 description 2
• 210000004261 periodontium Anatomy 0.000 description 2
• 210000003460 periosteum Anatomy 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 210000003800 pharynx Anatomy 0.000 description 2
• 230000037081 physical activity Effects 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 239000000049 pigment Substances 0.000 description 2
• 239000004810 polytetrafluoroethylene Substances 0.000 description 2
• 229920002635 polyurethane Polymers 0.000 description 2
• 239000004814 polyurethane Substances 0.000 description 2
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
• 238000007388 punch biopsy Methods 0.000 description 2
• 230000009103 reabsorption Effects 0.000 description 2
• 230000001850 reproductive effect Effects 0.000 description 2
• 238000002271 resection Methods 0.000 description 2
• 210000004918 root sheath Anatomy 0.000 description 2
• 210000001659 round ligament Anatomy 0.000 description 2
• 229920006395 saturated elastomer Polymers 0.000 description 2
• 230000036573 scar formation Effects 0.000 description 2
• 210000001732 sebaceous gland Anatomy 0.000 description 2
• 239000012679 serum free medium Substances 0.000 description 2
• 229920002379 silicone rubber Polymers 0.000 description 2
• 210000002027 skeletal muscle Anatomy 0.000 description 2
• 230000037075 skin appearance Effects 0.000 description 2
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
• 210000004267 spermatic cord Anatomy 0.000 description 2
• 210000001562 sternum Anatomy 0.000 description 2
• 230000003319 supportive effect Effects 0.000 description 2
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
• 210000000779 thoracic wall Anatomy 0.000 description 2
• 210000002303 tibia Anatomy 0.000 description 2
• 230000036572 transepidermal water loss Effects 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 229960001322 trypsin Drugs 0.000 description 2
• 230000007306 turnover Effects 0.000 description 2
• 206010046494 urge incontinence Diseases 0.000 description 2
• 230000002485 urinary effect Effects 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 210000005166 vasculature Anatomy 0.000 description 2
• 229940124549 vasodilator Drugs 0.000 description 2
• 239000003071 vasodilator agent Substances 0.000 description 2
• 230000000007 visual effect Effects 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
• RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
• CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
• GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010023728 Alloderm Proteins 0.000 description 1
• 206010001766 Alopecia totalis Diseases 0.000 description 1
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
• 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
• 108010001781 Apligraf Proteins 0.000 description 1
• 108010044811 Autologen Proteins 0.000 description 1
• 208000035404 Autolysis Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 235000000832 Ayote Nutrition 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
• 206010065687 Bone loss Diseases 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 206010057248 Cell death Diseases 0.000 description 1
• 206010008469 Chest discomfort Diseases 0.000 description 1
• 229920001287 Chondroitin sulfate Polymers 0.000 description 1
• 108090001069 Chymopapain Proteins 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 241001112696 Clostridia Species 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 240000007154 Coffea arabica Species 0.000 description 1
• 235000016795 Cola Nutrition 0.000 description 1
• 244000228088 Cola acuminata Species 0.000 description 1
• 235000011824 Cola pachycarpa Nutrition 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 240000004244 Cucurbita moschata Species 0.000 description 1
• 235000009854 Cucurbita moschata Nutrition 0.000 description 1
• 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
• 229920001076 Cutan Polymers 0.000 description 1
• 229920004934 Dacron® Polymers 0.000 description 1
• 206010011985 Decubitus ulcer Diseases 0.000 description 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
• 229920001605 Dextranomer Polymers 0.000 description 1
• 208000018672 Dilatation Diseases 0.000 description 1
• 206010013554 Diverticulum Diseases 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 208000005189 Embolism Diseases 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 206010063560 Excessive granulation tissue Diseases 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 206010015866 Extravasation Diseases 0.000 description 1
• 239000004606 Fillers/Extenders Substances 0.000 description 1
• 241000227647 Fucus vesiculosus Species 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 206010017711 Gangrene Diseases 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 244000194101 Ginkgo biloba Species 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 206010018691 Granuloma Diseases 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 206010018852 Haematoma Diseases 0.000 description 1
• 241001456088 Hesperocnide Species 0.000 description 1
• 208000034991 Hiatal Hernia Diseases 0.000 description 1
• 206010020028 Hiatus hernia Diseases 0.000 description 1
• 206010020112 Hirsutism Diseases 0.000 description 1
• 102000003710 Histamine H2 Receptors Human genes 0.000 description 1
• 108090000050 Histamine H2 Receptors Proteins 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• 206010020853 Hypertonic bladder Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
• LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 239000002211 L-ascorbic acid Substances 0.000 description 1
• 235000000069 L-ascorbic acid Nutrition 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 208000019693 Lung disease Diseases 0.000 description 1
• 206010050551 Lupus-like syndrome Diseases 0.000 description 1
• 206010064912 Malignant transformation Diseases 0.000 description 1
• 208000010728 Meckel diverticulum Diseases 0.000 description 1
• 241000213996 Melilotus Species 0.000 description 1
• 235000000839 Melilotus officinalis subsp suaveolens Nutrition 0.000 description 1
• 235000006679 Mentha X verticillata Nutrition 0.000 description 1
• 235000002899 Mentha suaveolens Nutrition 0.000 description 1
• 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
• 206010053236 Mixed incontinence Diseases 0.000 description 1
• 206010062575 Muscle contracture Diseases 0.000 description 1
• 206010050031 Muscle strain Diseases 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 208000014174 Oesophageal disease Diseases 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000237513 Pecten Species 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 206010035742 Pneumonitis Diseases 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 229920005830 Polyurethane Foam Polymers 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 241000200478 Prunus africana Species 0.000 description 1
• 235000000719 Prunus africana Nutrition 0.000 description 1
• 206010039509 Scab Diseases 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 206010040943 Skin Ulcer Diseases 0.000 description 1
• 206010040844 Skin exfoliation Diseases 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 201000009594 Systemic Scleroderma Diseases 0.000 description 1
• 206010042953 Systemic sclerosis Diseases 0.000 description 1
• 208000021945 Tendon injury Diseases 0.000 description 1
• 208000037063 Thinness Diseases 0.000 description 1
• ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
• RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
• 208000008312 Tooth Loss Diseases 0.000 description 1
• 208000005864 Tracheoesophageal Fistula Diseases 0.000 description 1
• 102400001320 Transforming growth factor alpha Human genes 0.000 description 1
• 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
• 206010046399 Ureteric dilatation Diseases 0.000 description 1
• 206010046442 Urethral dilatation Diseases 0.000 description 1
• 208000028484 Urethral disease Diseases 0.000 description 1
• 206010046555 Urinary retention Diseases 0.000 description 1
• 235000009108 Urtica dioica Nutrition 0.000 description 1
• 208000024780 Urticaria Diseases 0.000 description 1
• 206010046996 Varicose vein Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 206010066969 Vitello-intestinal duct remnant Diseases 0.000 description 1
• 206010053692 Wound complication Diseases 0.000 description 1
• INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 description 1
• 210000003489 abdominal muscle Anatomy 0.000 description 1
• 239000006096 absorbing agent Substances 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000007513 acids Chemical group 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 239000002390 adhesive tape Substances 0.000 description 1
• 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
• 229940061720 alpha hydroxy acid Drugs 0.000 description 1
• 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 229960002684 aminocaproic acid Drugs 0.000 description 1
• 229960003556 aminophylline Drugs 0.000 description 1
• FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
• 229960003942 amphotericin b Drugs 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 230000001548 androgenic effect Effects 0.000 description 1
• 229960003473 androstanolone Drugs 0.000 description 1
• 210000003423 ankle Anatomy 0.000 description 1
• 230000003260 anti-sepsis Effects 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 208000008784 apnea Diseases 0.000 description 1
• 210000000040 apocrine gland Anatomy 0.000 description 1
• 239000003886 aromatase inhibitor Substances 0.000 description 1
• 229940046844 aromatase inhibitors Drugs 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 230000000386 athletic effect Effects 0.000 description 1
• 210000003403 autonomic nervous system Anatomy 0.000 description 1
• 210000001099 axilla Anatomy 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 239000007640 basal medium Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 238000003339 best practice Methods 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
• 210000004763 bicuspid Anatomy 0.000 description 1
• 230000002146 bilateral effect Effects 0.000 description 1
• 239000005312 bioglass Substances 0.000 description 1
• 230000007698 birth defect Effects 0.000 description 1
• 235000019658 bitter taste Nutrition 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 235000021324 borage oil Nutrition 0.000 description 1
• 239000010474 borage seed oil Substances 0.000 description 1
• 230000036471 bradycardia Effects 0.000 description 1
• 208000006218 bradycardia Diseases 0.000 description 1
• 210000000621 bronchi Anatomy 0.000 description 1
• 210000005178 buccal mucosa Anatomy 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 229960001948 caffeine Drugs 0.000 description 1
• VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 230000005907 cancer growth Effects 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
• 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 description 1
• 230000008619 cell matrix interaction Effects 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 210000003850 cellular structure Anatomy 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 239000004568 cement Substances 0.000 description 1
• 229930183167 cerebroside Natural products 0.000 description 1
• 150000001784 cerebrosides Chemical class 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 230000035606 childbirth Effects 0.000 description 1
• 235000019219 chocolate Nutrition 0.000 description 1
• 210000003764 chromatophore Anatomy 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 229960002976 chymopapain Drugs 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 230000009194 climbing Effects 0.000 description 1
• 230000007012 clinical effect Effects 0.000 description 1
• 230000035602 clotting Effects 0.000 description 1
• 230000015271 coagulation Effects 0.000 description 1
• 238000005345 coagulation Methods 0.000 description 1
• 235000016213 coffee Nutrition 0.000 description 1
• 235000013353 coffee beverage Nutrition 0.000 description 1
• 230000037319 collagen production Effects 0.000 description 1
• 230000037369 collagen remodeling Effects 0.000 description 1
• 239000002131 composite material Substances 0.000 description 1
• 208000018631 connective tissue disease Diseases 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 208000006111 contracture Diseases 0.000 description 1
• 229940039231 contrast media Drugs 0.000 description 1
• 239000002872 contrast media Substances 0.000 description 1
• 230000001054 cortical effect Effects 0.000 description 1
• 210000003685 cricoid cartilage Anatomy 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 201000010251 cutis laxa Diseases 0.000 description 1
• 230000001351 cycling effect Effects 0.000 description 1
• 238000002574 cystoscopy Methods 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 229940070259 deflux Drugs 0.000 description 1
• 230000009748 deglutition Effects 0.000 description 1
• 230000003413 degradative effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 210000003298 dental enamel Anatomy 0.000 description 1
• 230000000994 depressogenic effect Effects 0.000 description 1
• 210000001047 desmosome Anatomy 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 229960002864 dextranomer Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 230000000378 dietary effect Effects 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 239000002934 diuretic Substances 0.000 description 1
• 229940030606 diuretics Drugs 0.000 description 1
• 230000035622 drinking Effects 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 210000003981 ectoderm Anatomy 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 239000000806 elastomer Substances 0.000 description 1
• 230000003028 elevating effect Effects 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000037149 energy metabolism Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 230000007071 enzymatic hydrolysis Effects 0.000 description 1
• 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 210000002815 epigastric artery Anatomy 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 230000010393 epithelial cell migration Effects 0.000 description 1
• 230000008472 epithelial growth Effects 0.000 description 1
• 230000003628 erosive effect Effects 0.000 description 1
• 208000008929 esophageal atresia Diseases 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 208000028299 esophageal disease Diseases 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 230000005713 exacerbation Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 230000036251 extravasation Effects 0.000 description 1
• 239000004744 fabric Substances 0.000 description 1
• 206010016165 failure to thrive Diseases 0.000 description 1
• 235000021149 fatty food Nutrition 0.000 description 1
• 230000035611 feeding Effects 0.000 description 1
• 102000013370 fibrillin Human genes 0.000 description 1
• 108060002895 fibrillin Proteins 0.000 description 1
• 230000019305 fibroblast migration Effects 0.000 description 1
• 230000003328 fibroblastic effect Effects 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 235000021323 fish oil Nutrition 0.000 description 1
• 229920002457 flexible plastic Polymers 0.000 description 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
• 210000000185 follicular epithelial cell Anatomy 0.000 description 1
• 235000021588 free fatty acids Nutrition 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 210000005200 frontal scalp Anatomy 0.000 description 1
• 230000027119 gastric acid secretion Effects 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 230000008303 genetic mechanism Effects 0.000 description 1
• 208000024693 gingival disease Diseases 0.000 description 1
• 201000005562 gingival recession Diseases 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 210000000224 granular leucocyte Anatomy 0.000 description 1
• 210000001126 granulation tissue Anatomy 0.000 description 1
• 230000037313 granulation tissue formation Effects 0.000 description 1
• 229940087603 grape seed extract Drugs 0.000 description 1
• 235000002532 grape seed extract Nutrition 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 235000009569 green tea Nutrition 0.000 description 1
• 230000003803 hair density Effects 0.000 description 1
• 210000000642 hair follicle dermal papilla cell Anatomy 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 230000009442 healing mechanism Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 208000024798 heartburn Diseases 0.000 description 1
• 230000023597 hemostasis Effects 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 235000008216 herbs Nutrition 0.000 description 1
• 229920006158 high molecular weight polymer Polymers 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 238000010562 histological examination Methods 0.000 description 1
• 230000003284 homeostatic effect Effects 0.000 description 1
• 210000004276 hyalin Anatomy 0.000 description 1
• 229920002674 hyaluronan Polymers 0.000 description 1
• 229960003160 hyaluronic acid Drugs 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 150000001261 hydroxy acids Chemical class 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000002390 hyperplastic effect Effects 0.000 description 1
• 210000003405 ileum Anatomy 0.000 description 1
• 230000008105 immune reaction Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 210000004283 incisor Anatomy 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 239000012212 insulator Substances 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000008611 intercellular interaction Effects 0.000 description 1
• 230000003601 intercostal effect Effects 0.000 description 1
• 210000003963 intermediate filament Anatomy 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 239000002085 irritant Substances 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 230000000302 ischemic effect Effects 0.000 description 1
• 208000016274 isolated tracheo-esophageal fistula Diseases 0.000 description 1
• 210000001847 jaw Anatomy 0.000 description 1
• 230000029774 keratinocyte migration Effects 0.000 description 1
• 108010075526 keratohyalin Proteins 0.000 description 1
• 230000003907 kidney function Effects 0.000 description 1
• 210000000244 kidney pelvis Anatomy 0.000 description 1
• 210000000629 knee joint Anatomy 0.000 description 1
• 230000006651 lactation Effects 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 238000002357 laparoscopic surgery Methods 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• 230000013190 lipid storage Effects 0.000 description 1
• 238000002504 lithotomy Methods 0.000 description 1
• 235000015263 low fat diet Nutrition 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 230000036212 malign transformation Effects 0.000 description 1
• 210000005075 mammary gland Anatomy 0.000 description 1
• 235000012054 meals Nutrition 0.000 description 1
• 230000005541 medical transmission Effects 0.000 description 1
• 230000005184 men's health Effects 0.000 description 1
• 210000000713 mesentery Anatomy 0.000 description 1
• 210000003716 mesoderm Anatomy 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000027939 micturition Effects 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 238000001964 muscle biopsy Methods 0.000 description 1
• 230000001114 myogenic effect Effects 0.000 description 1
• MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
• 210000000118 neural pathway Anatomy 0.000 description 1
• 230000010004 neural pathway Effects 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 229960003966 nicotinamide Drugs 0.000 description 1
• 235000005152 nicotinamide Nutrition 0.000 description 1
• 239000011570 nicotinamide Substances 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 210000002747 omentum Anatomy 0.000 description 1
• 235000015205 orange juice Nutrition 0.000 description 1
• 230000005305 organ development Effects 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000000278 osteoconductive effect Effects 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 210000003101 oviduct Anatomy 0.000 description 1
• 238000006213 oxygenation reaction Methods 0.000 description 1
• 230000036407 pain Effects 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 210000004417 patella Anatomy 0.000 description 1
• 210000000426 patellar ligament Anatomy 0.000 description 1
• 230000008756 pathogenetic mechanism Effects 0.000 description 1
• 231100000915 pathological change Toxicity 0.000 description 1
• 230000036285 pathological change Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 210000000062 pectoralis major Anatomy 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 201000001245 periodontitis Diseases 0.000 description 1
• 210000004303 peritoneum Anatomy 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 210000001184 pharyngeal muscle Anatomy 0.000 description 1
• 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
• 239000000467 phytic acid Substances 0.000 description 1
• 229940068041 phytic acid Drugs 0.000 description 1
• 235000002949 phytic acid Nutrition 0.000 description 1
• 230000019612 pigmentation Effects 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 239000005020 polyethylene terephthalate Substances 0.000 description 1
• 229920005594 polymer fiber Polymers 0.000 description 1
• 229940058401 polytetrafluoroethylene Drugs 0.000 description 1
• 239000011496 polyurethane foam Substances 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 230000002980 postoperative effect Effects 0.000 description 1
• 208000037920 primary disease Diseases 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 210000004061 pubic symphysis Anatomy 0.000 description 1
• 210000003456 pulmonary alveoli Anatomy 0.000 description 1
• 235000015136 pumpkin Nutrition 0.000 description 1
• ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
• 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
• 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
• 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
• 238000002601 radiography Methods 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 230000037309 reepithelialization Effects 0.000 description 1
• 238000002407 reforming Methods 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000001373 regressive effect Effects 0.000 description 1
• 230000002787 reinforcement Effects 0.000 description 1
• 238000009877 rendering Methods 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 229930002330 retinoic acid Natural products 0.000 description 1
• 230000000250 revascularization Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 229940041735 rexall Drugs 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 238000007142 ring opening reaction Methods 0.000 description 1
• 230000000630 rising effect Effects 0.000 description 1
• 210000000513 rotator cuff Anatomy 0.000 description 1
• 230000009291 secondary effect Effects 0.000 description 1
• 229930000044 secondary metabolite Natural products 0.000 description 1
• 230000028043 self proteolysis Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 238000010008 shearing Methods 0.000 description 1
• 210000002107 sheath cell Anatomy 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 238000004904 shortening Methods 0.000 description 1
• 229920002545 silicone oil Polymers 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 238000007390 skin biopsy Methods 0.000 description 1
• 231100000075 skin burn Toxicity 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 230000037380 skin damage Effects 0.000 description 1
• 230000036558 skin tension Effects 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 238000009987 spinning Methods 0.000 description 1
• 238000012453 sprague-dawley rat model Methods 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 238000011272 standard treatment Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 230000003068 static effect Effects 0.000 description 1
• 230000036262 stenosis Effects 0.000 description 1
• 208000037804 stenosis Diseases 0.000 description 1
• 210000005127 stratified epithelium Anatomy 0.000 description 1
• 210000000438 stratum basale Anatomy 0.000 description 1
• 208000022170 stress incontinence Diseases 0.000 description 1
• 210000003699 striated muscle Anatomy 0.000 description 1
• 210000003207 subcutaneous adipocyte Anatomy 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
• 235000013616 tea Nutrition 0.000 description 1
• 210000004876 tela submucosa Anatomy 0.000 description 1
• 230000002381 testicular Effects 0.000 description 1
• BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• 230000003813 thin hair Effects 0.000 description 1
• 238000012090 tissue culture technique Methods 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 230000008467 tissue growth Effects 0.000 description 1
• 230000017423 tissue regeneration Effects 0.000 description 1
• 229910052719 titanium Inorganic materials 0.000 description 1
• 239000010936 titanium Substances 0.000 description 1
• 229940100613 topical solution Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 231100000133 toxic exposure Toxicity 0.000 description 1
• 210000003437 trachea Anatomy 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• 230000008736 traumatic injury Effects 0.000 description 1
• 229960001727 tretinoin Drugs 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 206010048828 underweight Diseases 0.000 description 1
• 210000001942 upper esophageal sphincter Anatomy 0.000 description 1
• 210000001635 urinary tract Anatomy 0.000 description 1
• 208000019206 urinary tract infection Diseases 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 208000027185 varicose disease Diseases 0.000 description 1
• 230000002227 vasoactive effect Effects 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 201000002282 venous insufficiency Diseases 0.000 description 1
• 210000005198 vertex scalp Anatomy 0.000 description 1
• 239000001717 vitis vinifera seed extract Substances 0.000 description 1
• 239000011800 void material Substances 0.000 description 1
• 230000002747 voluntary effect Effects 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1